Publications
Detailed Information
Flavonoid Glycosides from Ulmus macrocarpa Inhibit Osteoclast Differentiation via the Downregulation of NFATc1
Cited 8 time in
Web of Science
Cited 5 time in Scopus
- Authors
- Issue Date
- 2022-02-15
- Publisher
- American Chemical Society
- Citation
- ACS Omega, Vol.7 No.6, pp.4840-4849
- Abstract
- The aim of this study was to isolate and identify chemical components with osteoclast differentiation inhibitory activity from Ulmus macrocarpa Hance bark. Spectroscopic analyses, including nuclear magnetic resonance (NMR) and electronic circular dichroism (ECD), resulted in the unequivocal elucidation of active compounds such as (2S)-naringenin-6-C-beta-D-glucopyranoside (1), (2R)-naringenin-6-C-beta-D-glucopyranoside (2), (2R,3S)-catechin-7-O-beta-D-xylopyranoside (3), (2R,3S)-catechin-7-O-beta-D-apiofuranoside (6), (2R,3R)-taxifolin-6-C-beta-D-glucopyranoside (7), and (2S,3S)-taxifolin-6-C-beta-D-glucopyranoside (8). Mechanistically, the compounds may exhibit osteoclast differentiation inhibitory activity via the downregulation of NFATc1, a master regulator involved in osteoclast formation. This is the first report of their inhibitory activities on the receptor activator of nuclear factor KB ligand (RANKL)-induced osteoclast differentiation in murine bone marrow-derived macrophages. These findings provide further scientific evidence for the rational application of the genus Ulmus for the amelioration or treatment of osteopenic diseases.
- ISSN
- 2470-1343
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.